COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
12/04/2018
Initiation of Phase 2b Trial on Track for Q3 2018 SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO ), a clinical-stage biopharmaceutical company focused on [...]
Establishment Labs Appoints Jeremy Livianu as General Counsel
12/04/2018
NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development [...]
HempAmericana Secures Initial Hemp Material with Potential CBD Oil Sales Yield of $20 Million
12/04/2018
NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company has now fully secured sufficient hemp input [...]
Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting
12/04/2018
Pratteln, Switzerland, April 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that a large majority of shareholders approved all proposals by the Board of Directors at the Annual General Meeting (AGM) held [...]
Paratek Pharmaceuticals Presenting New Data from Omadacycline Development Program at ECCMID 2018
12/04/2018
- First oral presentation of the results of OASIS-2, the Phase 3 omadacycline oral-only study in ABSSSI - Poster presentations include new microbiology analyses from OASIS-2 BOSTON, April 12, 2018 (GLOBE NEWSWIRE) -- [...]
Cutera Celebrates 20 Years of Best-In-Class Product Innovation
12/04/2018
DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- ASLMS 2018 ─ At the 2018 American Society for Laser Medicine and Surgery conference, Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”) celebrates 20 years of best-in- [...]
Millennium BlockChain Announces $3M Investment in ImpactPPA’s Decentralized Renewable Energy Platform
12/04/2018
Millennium BlockChain partners with ImpactPPA to disrupt renewable energy financing on the blockchain Las Vegas, NV / Manhattan Beach, CA, April 12, 2018 (GLOBE NEWSWIRE) -- Millennium BlockChain , Inc. (the “Company [...]
Novan Advances Organization and Strengthens Leadership Team
12/04/2018
CEO Role No Longer “Interim” Clinical Operations Role Established Finance Team Positioned for the Future MORRISVILLE, N.C., April 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today [...]
Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer
12/04/2018
PRESS RELEASE Lund, April 12, 2018 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that its partner NeoTX Therapeutics Ltd. will present new data for ANYARA (Naptumumab Estafenatox) at the Annual Meeting of [...]
Resverlogix Announces TSX Review Update
12/04/2018
CALGARY, Alberta, April 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) announced today it has received a 30-day extension to no later than May 14, 2018 for the TSX’s review [...]
AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting
12/04/2018
Monday, May 14, 2018 at 4:00 p.m. Eastern Time Hyatt Regency Orlando International Airport ALACHUA, Fla., April 12, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing [...]
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting
12/04/2018
Long-Term Safety and Efficacy Data in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome to be Presented LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) “GW,” “the Company” or “ [...]
Trillium Therapeutics to Report Preclinical Data on TTI-621 and TTI-622 at the AACR Annual Meeting 2018
12/04/2018
TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq: TRIL ) (TSX: TRIL ) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced [...]
Aeglea BioTherapeutics Presents New Phase 1/2 Trial Data Demonstrating Clinically Relevant Treatment Effects in Arginase 1 Deficiency Patients at the 2018 ACMG Annual Clinical Genetics Meeting
12/04/2018
Clinical Outcome Assessment Tools Detected and Quantified Baseline Abnormalities Clinically Relevant Improvement Seen in Multiple Neuromotor Tests Company to Host Clinical Update Conference Call Today at 8:30 a.m. ET [...]
Capricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor Day
12/04/2018
LOS ANGELES, April 12, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will be among the companies providing presentations at the Alliance for Regenerative Medicine’s (ARM’s) [...]
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases
12/04/2018
– Phase 3 IGNITE4 Results in Complicated Intra-Abdominal Infection Recognized as a ‘Best Rated Abstract’ – – Other Key Eravacycline and TP-6076 Data to Also be Highlighted – WATERTOWN, Mass., April 12, 2018 (GLOBE [...]
Microbot Medical’s Self-Cleaning Shunt Awarded a Grant by the European Commission
12/04/2018
Non-Dilutive Grant Strengthens Balance Sheet for Further Milestone Achievements HINGHAM, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in the [...]
EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™
12/04/2018
WATERTOWN, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT ) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic [...]
Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
12/04/2018
THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces the engagement of [...]

Pages